160 related articles for article (PubMed ID: 31733490)
1. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.
Witlox WJA; Ramaekers BLT; Joore MA; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder G; Haitjema T; Ubbels JF; Lagerwaard J; El Sharouni SY; Stigt JA; Smit EF; van Tinteren H; van der Noort V; Groen HJM; De Ruysscher DKM
Radiother Oncol; 2020 Mar; 144():65-71. PubMed ID: 31733490
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
Slotman BJ; Mauer ME; Bottomley A; Faivre-Finn C; Kramer GW; Rankin EM; Snee M; Hatton M; Postmus PE; Collette L; Senan S
J Clin Oncol; 2009 Jan; 27(1):78-84. PubMed ID: 19047288
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
[TBL] [Abstract][Full Text] [Related]
5. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
[TBL] [Abstract][Full Text] [Related]
7. Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study.
Kawata AK; Lenderking WR; Eseyin OR; Kerstein D; Huang J; Huang H; Zhang P; Lin HM
J Med Econ; 2019 Sep; 22(9):924-935. PubMed ID: 31125274
[No Abstract] [Full Text] [Related]
8. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270
[TBL] [Abstract][Full Text] [Related]
9. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis.
Li M; Wang T; Wen P; Wang X; Wu C
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788
[TBL] [Abstract][Full Text] [Related]
10. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
[TBL] [Abstract][Full Text] [Related]
12. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Le Péchoux C; Laplanche A; Faivre-Finn C; Ciuleanu T; Wanders R; Lerouge D; Keus R; Hatton M; Videtic GM; Senan S; Wolfson A; Jones R; Arriagada R; Quoix E; Dunant A;
Ann Oncol; 2011 May; 22(5):1154-1163. PubMed ID: 21139020
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.
Zeng H; Hendriks LEL; Witlox WJA; Groen HJM; Dingemans AC; Praag J; Belderbos J; Houben R; van der Noort V; De Ruysscher DKM
Radiother Oncol; 2023 Jun; 183():109627. PubMed ID: 36934893
[TBL] [Abstract][Full Text] [Related]
14. The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer.
Precival C; Landy M; Poole C; Mullaney L
Anticancer Res; 2018 Jan; 38(1):7-14. PubMed ID: 29277750
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review.
Lester JF; MacBeth FR; Coles B
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):690-4. PubMed ID: 15913909
[TBL] [Abstract][Full Text] [Related]
17. Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.
Khan I; Morris S; Pashayan N; Matata B; Bashir Z; Maguirre J
Health Qual Life Outcomes; 2016 Apr; 14():60. PubMed ID: 27072351
[TBL] [Abstract][Full Text] [Related]
18. Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.
Witlox WJA; Ramaekers BLT; Lacas B; Le Pechoux C; Pignon JP; Sun A; Wang SY; Hu C; Redman M; van der Noort V; Li N; Guckenberger M; van Tinteren H; Groen HJM; Joore MA; De Ruysscher DKM
Radiother Oncol; 2021 May; 158():40-47. PubMed ID: 33587968
[TBL] [Abstract][Full Text] [Related]
19. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
Nawrocki S; Sugajska A
BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
[TBL] [Abstract][Full Text] [Related]
20. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
